Salix 'Chrysocoma' it is much hardier and more long-lived than the Babylon Willow ("Salix babylonica"). This particular cultivar is easily distinguished from the other Golden Weeping Willow ("S." × "sepulcralis") by its androgynous catkins. A weeping tree, not much more than 22m high. Bark greyish-brown, deeply fissured. Twigs very slender, at first thinly subadpressed pubescent, soon becoming glabrous. Golden- or greenish-yellow in their first year, later becoming olive-green. Catkins appearing with the leaves in April, terminal on very short, spreading, leafy, lateral shoots, peduncle and rhachis softly villose. Catkins male, female or most commonly androgynous. Salix 'Chrysocoma' "Salix" × "sepulcralis" <nowiki>'Chrysocoma'</nowiki>, or
Salix alba Pliny the Elder and others believed willow bark could ease aches and pains and reduce fevers. It has long been used in Europe and China for the attempted treatment of these conditions. This remedy is also mentioned in texts from ancient Egypt, Sumer, and Assyria. The first "clinical trial" was reported by Reverend Edward Stone, a vicar from Chipping Norton in Oxfordshire, England, in 1763 with a successful treatment of malarial fever with the willow bark. The bark is often macerated in ethanol to produce a tincture. The active extract of the bark, called salicin, after the Latin name "Salix",